Passive enhanced safety surveillance for Vaxigrip and Intanza 15 µg in the United Kingdom and Finland during the northern hemisphere influenza season 2015/16

Enhanced safety surveillance (ESS) was conducted in the United Kingdom and Finland for Vaxigrip and Intanza 15 µg to comply with the European Medicines Agency interim guidance aimed to detect any potential increase in reactogenicity in near real time following the annual update of the influenza vacc...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Euro Surveill
Autors principals: Bricout, Hélène, Chabanon, Anne Laure, Souverain, Audrey, Sadorge, Christine, Vesikari, Timo, Caroe, Timothy David
Format: Artigo
Idioma:Inglês
Publicat: European Centre for Disease Prevention and Control (ECDC) 2017
Matèries:
Surveillance and Outbreak Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5434878/
https://ncbi.nlm.nih.gov/pubmed/28494843
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2807/1560-7917.ES.2017.22.18.30527
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars